Loading...
Development of a drug–disease simulation model for rituximab in follicular non-Hodgkin's lymphoma
AIM: Rituximab has dramatically improved the survival of patients with non-Hodgkin's lymphomas (NHL), but the dosing regimen currently used should be optimized. However, the concentration–effect relationship of rituximab has never been described by pharmacokinetic–pharmacodynamic (PK–PD) modell...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Blackwell Science Inc
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2780281/ https://ncbi.nlm.nih.gov/pubmed/19843059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2009.03494.x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|